Page last updated: 2024-11-03

1,2,5,8-tetrahydroxy anthraquinone and Nasopharyngeal Carcinoma

1,2,5,8-tetrahydroxy anthraquinone has been researched along with Nasopharyngeal Carcinoma in 1 studies

1,2,5,8-tetrahydroxy anthraquinone: structure in first source
quinalizarin : A tetrahydroxyanthraquinone having the four hydroxy groups at the 1-, 2-, 5- and 8-positions.

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pan, X1
Meng, R1
Yu, Z1
Mou, J1
Liu, S1
Sun, Z1
Zou, Z1
Wu, G1
Peng, G1

Other Studies

1 other study available for 1,2,5,8-tetrahydroxy anthraquinone and Nasopharyngeal Carcinoma

ArticleYear
Quinalizarin enhances radiosensitivity of nasopharyngeal carcinoma cells partially by suppressing SHP-1 expression.
    International journal of oncology, 2016, Volume: 48, Issue:3

    Topics: Anthraquinones; Apoptosis; Binding Sites; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Proliferatio

2016